Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction

Know about the book -

Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction is written by Harry Karmouty-Quintana and published by Frontiers Media SA. It's available with International Standard Book Number or ISBN identification 2889457737 (ISBN 10) and 9782889457731 (ISBN 13).

Pulmonary hypertension (PH) is a disorder of the pulmonary vasculature defined by increased mean pulmonary arterial pressure (mPAP) leading to right ventricle (RV) hypertrophy and dysfunction, right-sided heart failure and ultimately death. PH is a common complication of chronic lung diseases (CLD) including idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary disease (COPD) where it is classified as Group 3 PH by the WHO. It can also be associated with cardiovascular conditions such as left-heart disease (classified as Group 2 PH) or appear on its own as pulmonary arterial hypertension (PAH) and classified as Group1 PH. In all of these cases the diagnosis of pulmonary hypertension is strongly associated with increased morbidity and mortality. The focus of this Research Topic is to enhance our understanding of the mechanisms that contribute to the pathophysiology of pulmonary hypertension and right ventricle hypertrophy.